Centessa Pharmaceuticals (CNTA) Acquisitions (2021)
Centessa Pharmaceuticals (CNTA) reported Acquisitions of -$4.6 million for Q4 2021, down 106.76% on a QoQ basis from $68.0 million in Q1 2021.
Centessa Pharmaceuticals (CNTA) has 1 years of Acquisitions data on file, last reported at -$4.6 million in Q4 2021.
- Quarterly Acquisitions changed N/A year-over-year to -$4.6 million in Q4 2021, while the trailing twelve-month figure through Sep 2022 was -$4.6 million (down 106.76% YoY) and the FY2021 annual result came in at $63.4 million, changed N/A from the prior year.
- Acquisitions declined to -$4.6 million in Q4 2021 per CNTA's latest filing, from $68.0 million in the prior quarter.
- Across five years, Acquisitions topped out at $68.0 million in Q1 2021 and bottomed at -$4.6 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Centessa Pharmaceuticals | 6.12 Bn | 6.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -4.60 Mn |
| Mar 31, 2021 | 68.04 Mn |